BREAKING NEWS

AstraZeneca expands COVID-19 vaccine supply tie-up with Oxford Biomedica

By REUTERS

SEPTEMBER 1, 2020 10:42

AstraZeneca has expanded its agreement with Oxford Biomedica to make and supply the drugmaker's COVID-19 vaccine candidate, in a deal that will pay the gene and cell therapy firm $15 million upfront and an additional $35 million plus other costs by the end of 2021.

Oxford Biomedica said in a statement that under the deal it would mass-produce the potential vaccine, AZD1222, for the novel coronavirus for a period of 18 months, which may be further extended by another 18 months into 2022 and 2023.

US: we’re not involved in Lebanon attack, still time for diplomacy

By TOVAH LAZAROFF

09/20/2024 05:45 PM

Unmanned boat acting 'unpredictably' near Yemen, authorities investigate

By REUTERS

09/20/2024 05:34 PM

PM Netanyahu postpones trip to New York following Beirut strike

By JERUSALEM POST STAFF

09/20/2024 05:32 PM

British FM David Lammy discusses Beirut strike with gov't officials

By REUTERS

09/20/2024 05:30 PM